Back
Emergent BioSolutions Vs. Abbott Laboratories Industry Stock Comparison
Buy
70
EBS
Emergent BioSolutions
Last Price:
10.89
Seasonality Move:
5.89%
Buy
63
ABT
Abbott Laboratories
Last Price:
116.43
Seasonality Move:
1.93%
Buy
70
Emergent BioSolutions (EBS)
is a Buy
Is Emergent BioSolutions a Buy, Sell or Hold?
- The current Emergent BioSolutions [EBS] share price is $11.97. The Score for EBS is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- EBS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Abbott Laboratories (ABT)
is a Buy
Is Abbott Laboratories a Buy, Sell or Hold?
- The current Abbott Laboratories [ABT] share price is $116.80. The Score for ABT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- ABT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EBS Stock Price Chart
What is Emergent BioSolutions's stock price today?
-
The Emergent BioSolutions share price today is $11.97
The current trend is moderately bullish and EBS is experiencing selling pressure, which indicates risk of future bearish movement.
ABT Stock Price Chart
What is Abbott Laboratories's stock price today?
-
The Abbott Laboratories share price today is $116.80
The current trend is moderately bullish and ABT is experiencing slight selling pressure.
EBS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 71.01 | Buy |
| Chaikin Money Flow: | -1016313 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.56 - 10.3) | Buy |
| Bollinger Bands (100): | (7.08 - 10.94) | Buy |
ABT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.49 | Buy |
| Relative Strength Index (14 RSI): | 53.4 | Buy |
| Chaikin Money Flow: | -1635179 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.46 - 117.68) | Buy |
| Bollinger Bands (100): | (106 - 116.2) | Buy |
EBS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.98 | Buy |
| 20-day SMA: | 9.57 | Buy |
| 50-day SMA: | 8.49 | Buy |
| 200-day SMA: | 6.13 | Buy |
| 8-day EMA: | 10.46 | Buy |
| 20-day EMA: | 9.69 | Buy |
| 50-day EMA: | 9.05 | Buy |
| 200-day EMA: | 7.33 | Buy |
ABT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 116.61 | Buy |
| 20-day SMA: | 116.31 | Buy |
| 50-day SMA: | 115.3 | Buy |
| 200-day SMA: | 110.65 | Buy |
| 8-day EMA: | 116.41 | Buy |
| 20-day EMA: | 116 | Buy |
| 50-day EMA: | 114.64 | Buy |
| 200-day EMA: | 110.53 | Buy |
Emergent BioSolutions Earnings Growth & EBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.87 per share, and an increase next year of $3.99 per share.
Abbott Laboratories Earnings Growth & ABT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.48 per share.
Emergent BioSolutions Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Abbott Laboratories Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||